Finance

Beta
Lists
SGHT:NASDAQ
Sight Sciences Inc
$5.69
+4.21%
(+0.23) 1D
$5.69
-0.00% (-0.00010)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGHT...
Open
$5.44
High
$5.70
Low
$5.37
Mkt. cap
309.59M
Avg. vol.
164.92K
Volume
764.00K
52-wk high
$9.24
52-wk low
$3.11
EPS
-$0.71
Beta
2.41
Shares outstanding
54.41M
No. of employees
186
Open
$5.44
High
$5.70
Low
$5.37
Mkt. cap
309.59M
Avg. vol.
164.92K
Volume
764.00K
52-wk high
$9.24
52-wk low
$3.11
EPS
-$0.71
Beta
2.41
Shares outstanding
54.41M
No. of employees
186
News stories
From sources across the web
About Sight Sciences Inc
CEO-
Employees186
Founded2010
Headquarters-
SectorMedical device
Websitesightsciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to SGHT in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SGHT in the last 3 months.
Highest
Current $5.69
$12.00 (+110.90%)
Average
$8.54 (+50.09%)
Lowest
$5.15 (-9.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Hold
Maintained
$5.15
-9.5%
05/29/2026
Steven Lichtman
William Blair
Buy
Reiterated
-
-
05/07/2026
Ryan Meyers
Lake Street
Buy
Reiterated
$12.00
+110.9%
05/07/2026
David Saxon
Needham
Hold
Maintained
-
-
05/07/2026
Thomas Stephan
Stifel Nicolaus
Buy
Reiterated
$8.00
+40.6%
05/07/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
$9.00
+58.2%
05/07/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$12.00
+110.9%
03/30/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
$8.00
+40.6%
03/11/2026
Danielle Antalffy
UBS
Buy
Reiterated
$11.00
+93.3%
03/06/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.24 / -$0.21
-12.50%miss
Revenue / Est. (USD)
19.70M / 18.73M
+5.16%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.56M
19.91M
20.38M
19.70M
Cost of goods sold
2.98M
2.71M
2.60M
2.72M
Cost of revenue
2.98M
2.71M
2.60M
2.72M
Research and development expenses
4.39M
2.35M
2.44M
2.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.87M
19.95M
19.02M
21.44M
Operating expense
28.25M
22.30M
21.46M
23.99M
Total operating expenses
31.23M
25.01M
24.05M
26.71M
Operating income
-11.67M
-5.10M
-3.67M
-7.01M
Other non operating income
24.00K
-2.00K
-30.00K
-29.00K
EBT including unusual items
-11.90M
-8.25M
-4.15M
-12.97M
EBT excluding unusual items
-11.90M
-5.45M
-4.15M
-7.57M
Income tax expense
40.00K
-79.00K
8.00K
11.00K
Effective tax rate
-0.34%
0.96%
-0.19%
-0.08%
Other operating expenses
-
-
-
-
Net income
-11.94M
-8.17M
-4.16M
-12.98M
Net profit margin
-61.04%
-41.04%
-20.42%
-65.89%
Earnings per share
-0.23
-0.16
-0.08
-0.24
Interest and investment income
1.03M
965.00K
834.00K
741.00K
Interest expense
-1.28M
-1.31M
-1.29M
-1.27M
Net interest expenses
-258.00K
-341.00K
-455.00K
-527.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.54M
-5.00M
-3.56M
-6.91M
Gain or loss from assets sale
-
4.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of SGHT
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer